- Global Pharma News & Resources

Oral Vaccines Market Sales Projection, Growth Estimation, Size Analysis, Key Profile Insights, Share Value and Dynamics By 2027

Vaccines are biologically prepared products, which provide active acquired immunity to diseases such as cholera, polio, rotavirus, smallpox, yellow fever and others. A vaccine comprise an agent resembling to a disease-causing microorganism. The vaccines are generally developed from live-attenuated or killed forms of the disease-causing microorganism, its toxins, or its surface proteins.

Oral administration of vaccines is the most convenient way of vaccination, owing to the factors such as oral vaccines are non-invasive, safe, and suitable for all age groups, especially children. Oral vaccines are mostly preferred for mass vaccination and are mostly liquid filled in sachet or blister. Oral vaccines are commonly available for diseases such as typhoid, cholera, adenovirus, rotavirus, and others.

Request to download and view Sample Report:

Global Oral Vaccines Market Drivers

Rising incidences of infections such as cholera, tuberculosis, and others are expected to propel growth of the oral vaccine market over the forecast period. For instance, according to the World Health Organization (WHO), 2019, around 1.3 million to 4.0 million cases of cholera and approximately 10 million cases of tuberculosis were reported globally in the year 2018.

Moreover, increasing government support towards new product approvals are expected to drive the oral vaccines market growth. For instance, in October 2018, Sanofi Pasteur received the prequalification status from the World Health Organization (WHO) for its inactivated Polio Vaccine (IPV), ShanIPV. The prequalification program ensures that the vaccines are safe and effective for the immunization programs. The prequalification status qualifies the vaccine ShanIPV for purchase by the agencies of the United Nations for various immunization programs.

Global Oral Vaccines Market Regional Insights

North America accounted for the largest market share in 2018, owing to development of new technologies for enhancing vaccine utility in the region. For instance, in February 2019, according to the journal of the American Chemical Society (ACS), Nano Letters, researchers have developed the oral vaccines coupled with micromotors. The micromotors prevent the active agents in the vaccines from acidic condition in stomach, in order to enhance the utility of the vaccines.

Tailored Information as per niche requirement:

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @

Asia Pacific is also expected to witness significant growth in oral vaccines market due to increasing government initiatives and various immunization campaigns. For instance, in August 2019, the United Nations International Children’s Emergency Fund (UNICEF), reported that around 400,000 people including 65,000 children were vaccinated in a six day oral cholera vaccination campaign run by the local health authorities of Yemen in three cities of Yemen (Aden, Al Dhale’e, and Taizz).

Global Oral Vaccines Market – Competitive Landscape

Key player in oral vaccines market are focused on strategic mergers and acquisitions to promote their product in global market. For instance, in February 2019, Bharat Biotech acquired Chiron Behring vaccines, a manufacturer of rabies vaccine and subsidiary of GlaxoSmithKline. The acquisition enhanced Bharat Biotech offerings for rabies vaccine and strengthened its market presence.

Key players operating in the global oral vaccines market include GlaxoSmithKline, Sanofi, Merck, Serum Institute of India pvt ltd, Swiss serum and vaccine institute Brene, Janssen pharmaceuticals, Paxvax corporation ltd, Valneva Canada, Shanghai Bravo bio Co ltd, Abbott Biologicals, MSD, Novavax, and Takeda.

To understand Research Methodology, please click

Global Oral Vaccine Market – Market Taxonomy

 On the basis of vaccine type, the global oral vaccine market is segmented into:

  • Live Attenuated
  • Inactive
  • Recombinant
  • Others

On the basis of application, the global oral vaccines market is segmented into:

  • Polio
  • Tuberculosis
  • Rabies
  • Influenza
  • Cholera
  • Others

On the basis of end user, the global oral vaccines market is segmented into:

  • Hospitals
  • Clinics
  • Government Organizations
  • Others

On the basis of region, the global oral vaccines market is segmented into:

  • North America
  • Europe
  • Latin America
  • Asia Pacific Middle East
  • Africa
About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website –


Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 14-Jan-2021